Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 218607 (Jun 27, 2025)

Issued June 27, 2025

Issued

June 27, 2025

Application

NDA 505b1 • 218607

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Response due June 27, 2026Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…